Skip to main content
Top
Published in: European Archives of Oto-Rhino-Laryngology 12/2020

01-12-2020 | COVID-19 | Short Communication

Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life

Authors: Simone Meini, Lorenzo Roberto Suardi, Michele Busoni, Anna Teresa Roberts, Alberto Fortini

Published in: European Archives of Oto-Rhino-Laryngology | Issue 12/2020

Login to get access

Abstract

Purpose

COVID-19 displays a variety of clinical manifestations; in pauci-symptomatic patients olfactory (OD) and gustatory dysfunctions (GD) may represent the first or only symptom. This topic is currently arousing great interest, and a growing number of papers are being published. Aim of this study is to investigate the timing of recovery from OD and GD in a real-life population hospitalized for COVID-19.

Methods

We followed up by a phone interview the first 100 patients discharged a month earlier from three Italian non-intensive care wards.

Results

All 100 patients were Caucasian, mean age was 65 years, 60% were males. Forty-two patients (mean age 63 years) experienced subjective chemosensory dysfunctions (29 OD and 41 GD): the male/female ratio was 2:1; 83% reported a complete or near complete recovery at follow-up. The recovery rate was not significantly different between males and females. The mean duration of OD and GD was 18 and 16 days, respectively. The mean recovery time from OD or GD resulted significantly longer for females than for males (26 vs 14 days, P = 0.009). Among the 42 symptomatic, the mean age of males was significantly higher than that of females (66 vs 57 years, P = 0.04), while the opposite was observed in the 58 asymptomatic patients (60 vs 73 years, P = 0.0018).

Conclusions

Recovery from OD or GD was rapid, occurring within 4 weeks in most patients. Chemosensory dysfunctions in women was less frequent, but longer lasting. The value of our study is its focus on a population of hospitalized patients significantly older than those previously described, and the additional data on gender differences.
Literature
3.
go back to reference Lee DY, Lee WH, Wee JH, Kim JW (2014) Prognosis of postviral olfactory loss: follow-up study for longer than one year. Am J Rhinol Allergy 28(5):419–422CrossRefPubMed Lee DY, Lee WH, Wee JH, Kim JW (2014) Prognosis of postviral olfactory loss: follow-up study for longer than one year. Am J Rhinol Allergy 28(5):419–422CrossRefPubMed
5.
go back to reference Cai H (2020) Sex Difference and Smoking Predisposition in Patients With COVID-19. Lancet Respir Med. Accessed 2020 Mar 11 [Online ahead of print] Cai H (2020) Sex Difference and Smoking Predisposition in Patients With COVID-19. Lancet Respir Med. Accessed 2020 Mar 11 [Online ahead of print]
6.
go back to reference Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(S29):1–464PubMed Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S et al (2020) European position paper on rhinosinusitis and nasal polyps 2020. Rhinology 58(S29):1–464PubMed
7.
go back to reference Rozin P (1982) Taste-smell confusions” and the duality of the olfactory sense. Percept Psychophys 31(4):397–401CrossRefPubMed Rozin P (1982) Taste-smell confusions” and the duality of the olfactory sense. Percept Psychophys 31(4):397–401CrossRefPubMed
10.
go back to reference Kaya KS, Akpınar M, Turk B, Seyhun N, Cankaya M, Coskun BU (2020) Olfactory function in patients with obstructive sleep apnea using positive airway pressure. Ear Nose Throat J 99(4):239–244CrossRefPubMed Kaya KS, Akpınar M, Turk B, Seyhun N, Cankaya M, Coskun BU (2020) Olfactory function in patients with obstructive sleep apnea using positive airway pressure. Ear Nose Throat J 99(4):239–244CrossRefPubMed
15.
go back to reference Scangas GA, Bleier BS (2017) Anosmia: differential diagnosis, evaluation, and management. Am J Rhinol Allergy 31:e3–7CrossRef Scangas GA, Bleier BS (2017) Anosmia: differential diagnosis, evaluation, and management. Am J Rhinol Allergy 31:e3–7CrossRef
16.
go back to reference Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271–280CrossRefPubMedPubMedCentral Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ace2 and tmprss2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271–280CrossRefPubMedPubMedCentral
18.
go back to reference Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X et al (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12(1):8CrossRefPubMedPubMedCentral Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X et al (2020) High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 12(1):8CrossRefPubMedPubMedCentral
19.
go back to reference Belowska-Bień K, Szeląg E, Szeląg J, Skrzypiec-Spring M (2017) Bradykinin—an undervalued mediator? Post N Med 8:440–446 Belowska-Bień K, Szeląg E, Szeląg J, Skrzypiec-Spring M (2017) Bradykinin—an undervalued mediator? Post N Med 8:440–446
20.
go back to reference Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ et al (2004) Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41(6):849–857CrossRefPubMed Bandell M, Story GM, Hwang SW, Viswanath V, Eid SR, Petrus MJ et al (2004) Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 41(6):849–857CrossRefPubMed
21.
go back to reference Chen EY, Emerich DF, Bartus RT, Kordower JH (2000) B2 bradykinin receptor immunoreactivity in rat brain. J Comp Neurol 427(1):1–18CrossRefPubMed Chen EY, Emerich DF, Bartus RT, Kordower JH (2000) B2 bradykinin receptor immunoreactivity in rat brain. J Comp Neurol 427(1):1–18CrossRefPubMed
22.
go back to reference Reinhard A, Ikonomidis C, Broome M, Gorostidi F (2020) Anosmia and COVID-19. Rev Med Suisse 16:849–851PubMed Reinhard A, Ikonomidis C, Broome M, Gorostidi F (2020) Anosmia and COVID-19. Rev Med Suisse 16:849–851PubMed
Metadata
Title
Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life
Authors
Simone Meini
Lorenzo Roberto Suardi
Michele Busoni
Anna Teresa Roberts
Alberto Fortini
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Keywords
COVID-19
Anosmia
Published in
European Archives of Oto-Rhino-Laryngology / Issue 12/2020
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-020-06102-8

Other articles of this Issue 12/2020

European Archives of Oto-Rhino-Laryngology 12/2020 Go to the issue